Prioritizing your skincare routine is essential to maintaining a youthful glow and tackling early signs of aging As you ...

The brand also sampled Anthelios sunscreens at product-sampling kiosks throughout the grounds, with full-sized sunscreens for sale at US Open Collection stores. La Roche-Posay proudly partners ...

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

Every day is a sunscreen day with La Roche-Posay Anthelios. Sign up & receive 20% off all skincare sets for the ultimate winter skin routine. Winter is here, which means cold nights, long lunches ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Roche raised hopes this year that it had a future blockbuster drug on its hands after early trial results ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Roche shares fall 3.5% Early study trial showed high rate of temporary side effects JP Morgan analysts say heart rate increase is as a concern Roche plans slower ramp-up of pill dose in next trial ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...